Format

Send to

Choose Destination
JAMA. 2019 Feb 19;321(7):651-653. doi: 10.1001/jama.2019.0236.

Mitigating Health Risks of Prescription Drugs: Lessons From FDA Oversight of Opioid Products.

Author information

1
Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
2
Deputy Editor.
PMID:
30778584
DOI:
10.1001/jama.2019.0236
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center